Results 181 to 190 of about 1,207,929 (290)
ABSTRACT Objective To investigate the factors associated with non‐vasomotor menopause symptoms among women in the UK, focusing on the perceived importance of specific symptoms and their association with demographic and treatment‐related factors. Design A cross‐sectional online survey.
Rhianna Davies +12 more
wiley +1 more source
Diet quality, body weight, and postmenopausal hot flashes: a secondary analysis of a randomized clinical trial. [PDF]
Brennan H +5 more
europepmc +1 more source
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell +4 more
wiley +1 more source
Higher amounts of habitual physical activity changes the relationship between hot flashes and subclinical cardiovascular disease risk. [PDF]
Witkowski S +6 more
europepmc +1 more source
Modern Management of the Menopause: Are We Measuring What Matters?
ABSTRACT Objective Assess uptake of the Core Outcomes in Menopause (COMMA) core outcome sets (COS) and examine whether frontline treatments for vasomotor and genitourinary symptoms have been evaluated against these key outcomes. Design Methodological review. Setting Published literature and international clinical trial registries.
Joscelyn Gan +7 more
wiley +1 more source
ABSTRACT Objective To examine the effects of Clinical Pilates (CP) training and aerobic exercise (AE) on menopausal symptoms, depressive symptoms, quality of life (QoL), and sleep quality in postmenopausal women. Design Parallel‐group randomised controlled trial. Setting A Healthy Life Center in Bitlis, Turkey.
Başak Can, Serkan Usgu, Günseli Usgu
wiley +1 more source
Identification of atypical hypoglycemia via continuous glucose monitoring in a patient presenting with hot flashes. [PDF]
Omura T +8 more
europepmc +1 more source
ABSTRACT Background Elinzanetant, a novel, dual neurokinin‐targeted therapy, has been approved in various geographies for the treatment of moderate‐to‐severe vasomotor symptoms (VMS) associated with menopause. Objective To compare the efficacy of elinzanetant with non‐hormonal pharmaceutical treatments (nHT) in alleviating VMS.
Piotr Wojciechowski +8 more
wiley +1 more source
The influence of habitual physical activity and sedentary behavior on objective and subjective hot flashes at midlife. [PDF]
Witkowski S +4 more
europepmc +1 more source

